Genetic analysis of circulating tumor cells in pancreatic cancer patients: A pilot study

被引:14
|
作者
Goerner, Karin [1 ]
Bachmann, Jeannine [2 ]
Holzhauer, Claudia [1 ]
Kirchner, Roland [1 ]
Raba, Katharina [4 ]
Fischer, Johannes C. [4 ]
Martignoni, Marc E. [2 ]
Schiemann, Matthias [3 ]
Alunni-Fabbroni, Marianna [1 ]
机构
[1] Beckman Coulter Biomed GmbH, D-81377 Munich, Germany
[2] Tech Univ Munich, Dept Surg, Klinikum Rechts Isar, D-81675 Munich, Germany
[3] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany
[4] Univ Dusseldorf, Inst Transplantat Diagnost & Cell Therapy, Fac Med, D-40225 Dusseldorf, Germany
关键词
Circulating tumor cells; Flow cytometry; Genetic profile; Pancreatic cancer; RT-PCR; METASTATIC BREAST-CANCER; PERIPHERAL-BLOOD; PROGNOSTIC-FACTOR; LIQUID BIOPSY; CHEMOTHERAPY; PROGRESSION; SIZE;
D O I
10.1016/j.ygeno.2015.02.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Pancreatic cancer is one of the most aggressive malignant tumors, mainly due to an aggressive metastasis spreading. In recent years, circulating tumor cells became associated to tumor metastasis. Little is known about their expression profiles. The aim of this study was to develop a complete workflow making it possible to isolate circulating tumor cells from patients with pancreatic cancer and their genetic characterization. Results: We show that the proposedworkflow offers a technical sensitivity and specificity high enough to detect and isolate single tumor cells. Moreover our approach makes feasible to genetically characterize single CTCs. Conclusions: Our work discloses a complete workflow to detect, count and genetically analyze individual CTCs isolated from blood samples. This method has a central impact on the early detection of metastasis development. The combination of cell quantification and genetic analysis provides the clinicians with a powerful tool not available so far. (C) 2015 Published by Elsevier Inc.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 50 条
  • [21] Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy: A Pilot Study
    Eblan, M. J.
    Myung, J. H.
    Caster, J. M.
    Miller, S. M.
    Wang, K.
    Moore, D. T.
    Chera, B. S.
    Hong, S.
    Wang, A. Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S105 - S106
  • [22] A pilot study of cdc6 as a biomarker for circulating tumor cells in patients with lung cancer
    An, Cheng
    Liu, Guijian
    Cheng, Shi
    Pang, Bo
    Sun, Shipeng
    Zhang, Yaying
    Pan, Zhongdai
    Kang, Xixiong
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (06)
  • [23] Pancreatic Circulating Tumor Cells as a Diagnostic Adjunct in Pancreatic Cancer
    Ankeny, J. S.
    Hou, S.
    Song, M.
    Rochefort, M. M.
    Girgis, M. D.
    Isacoff, W. H.
    Tseng, H.
    Tomlinson, J. S.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S156 - S156
  • [24] Pancreatic circulating tumor cells as a diagnostic adjunct in pancreatic cancer
    Ankeny, Jacob S.
    Hou, Shuang
    Lin, Millicent
    OuYang, Hank
    Song, Min
    Rochefort, Matthew M.
    Girgis, Mark D.
    Isacoff, William H.
    Wainberg, Zev A.
    Tseng, Hsian-Rong
    Tomlinson, James S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [25] Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer
    Riva, Francesca
    Dronov, Oleksii I.
    Khomenko, Dmytro I.
    Huguet, Florence
    Louvet, Christophe
    Mariani, Pascale
    Stern, Marc-Henri
    Lantz, Olivier
    Proudhon, Charlotte
    Pierga, Jean-Yves
    Bidard, Francois-Clement
    MOLECULAR ONCOLOGY, 2016, 10 (03) : 481 - 493
  • [26] A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
    L Khoja
    A Backen
    R Sloane
    L Menasce
    D Ryder
    M Krebs
    R Board
    G Clack
    A Hughes
    F Blackhall
    J W Valle
    C Dive
    British Journal of Cancer, 2012, 106 : 508 - 516
  • [27] A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
    Khoja, L.
    Backen, A.
    Sloane, R.
    Menasce, L.
    Ryder, D.
    Krebs, M.
    Board, R.
    Clack, G.
    Hughes, A.
    Blackhall, F.
    Valle, J. W.
    Dive, C.
    BRITISH JOURNAL OF CANCER, 2012, 106 (03) : 508 - 516
  • [28] PILOT TRIAL FOR THE QUANTITATIVE DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH PROSTATE CANCER
    Thalgott, M. K.
    Nawroth, R.
    Andergassen, U.
    Rack, B. K.
    Maurer, T.
    Heck, M.
    Horn, T.
    Herkommer, K.
    Gschwend, J. E.
    Retz, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 275 - 275
  • [29] Circulating tumor cells in pancreatic cancer patients: Methods of detection and clinical implications
    Tjensvoll, Kjersti
    Nordgard, Oddmund
    Smaaland, Rune
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (01) : 1 - 8
  • [30] Circulating Tumor Cells in Pancreatic Cancer Patients: Efficacy in Diagnosis and Value in Prognosis
    Xie, Zhi-Bo
    Yao, Lie
    Jin, Chen
    Fu, De-Liang
    DISCOVERY MEDICINE, 2016, 22 (120) : 121 - 128